4‑((15‑Oxoretin‑15‑yl)amino)benzoic acid, also known as Retinamidic acid, is a retinoid derivative. It has no officially approved medical uses but appears in patent literature for potential skin-whitening and tyrosinase inhibition. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include N-(4-Carboxyphenyl)retinamide, (BENZOIC ACID, 4-((15-OXORETIN-15-YL)AMINO)-) and QGJ09HO5S0. Its PubChem CID is 6505394.
Retinamidic acid
| CAS No | 74193-17-2 |
|---|---|
| Molecular Formula | C27H33NO3 |
| Molecular Weight | 419.6 g/mol |
| Synonyms | 4-[[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]benzoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
4‑((15‑Oxoretin‑15‑yl)amino)benzoic acid, also known as Retinamidic acid, is a retinoid derivative. It has no officially approved medical uses but appears in patent literature for potential skin-whitening and tyrosinase inhibition.
The listed CAS number is 74193-17-2.
The listed molecular formula is C27H33NO3.
The listed molecular weight is 419.6 g/mol.
4-[[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]benzoic acid.
The source lists N-(4-Carboxyphenyl)retinamide, (BENZOIC ACID, 4-((15-OXORETIN-15-YL)AMINO)-) and QGJ09HO5S0.